Trial · NCT03125902
Adverse events358
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 358
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ANAEMIA | Blood and lymphatic system disorders | Atezolizumab + Paclitaxel | 128 | 431 | 277 |
| other | ANAEMIA | Blood and lymphatic system disorders | Placebo + Paclitaxel | 66 | 220 | 134 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | Atezolizumab + Paclitaxel | 56 | 431 | 181 |
| other | LEUKOPENIA | Blood and lymphatic system disorders | Placebo + Paclitaxel | 20 | 220 | 44 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Atezolizumab + Paclitaxel | 98 | 431 | 253 |
| other | NEUTROPENIA | Blood and lymphatic system disorders | Placebo + Paclitaxel | 48 | 220 | 103 |
| other | HYPERTHYROIDISM | Endocrine disorders | Atezolizumab + Paclitaxel | 25 | 431 | 28 |
| other | HYPERTHYROIDISM | Endocrine disorders | Placebo + Paclitaxel | 0 | 220 | 0 |
| other | HYPOTHYROIDISM | Endocrine disorders | Atezolizumab + Paclitaxel | 49 | 431 | 65 |
| other | HYPOTHYROIDISM | Endocrine disorders | Placebo + Paclitaxel | 6 | 220 | 6 |
| other | ABDOMINAL PAIN | Gastrointestinal disorders | Atezolizumab + Paclitaxel | 37 | 431 | 45 |
| other | ABDOMINAL PAIN | Gastrointestinal disorders | Placebo + Paclitaxel | 19 | 220 | 21 |
| other | ABDOMINAL PAIN UPPER | Gastrointestinal disorders | Atezolizumab + Paclitaxel | 42 | 431 | 47 |
| other | ABDOMINAL PAIN UPPER | Gastrointestinal disorders | Placebo + Paclitaxel | 15 | 220 | 22 |
| other | CONSTIPATION | Gastrointestinal disorders | Atezolizumab + Paclitaxel | 82 | 431 | 103 |
| other | CONSTIPATION | Gastrointestinal disorders | Placebo + Paclitaxel | 33 | 220 | 56 |
| other | DIARRHOEA | Gastrointestinal disorders | Atezolizumab + Paclitaxel | 130 | 431 | 209 |
| other | DIARRHOEA | Gastrointestinal disorders | Placebo + Paclitaxel | 50 | 220 | 88 |
| other | DRY MOUTH | Gastrointestinal disorders | Atezolizumab + Paclitaxel | 24 | 431 | 32 |
| other | DRY MOUTH | Gastrointestinal disorders | Placebo + Paclitaxel | 8 | 220 | 9 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03125902/events